×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

AnaptysBio Inc. (ANAB) NASDAQ

$22.52 1.14 (5.33%)

Market Cap: $602.70M

As of 03/28/24 04:00 PM EDT. Market closed.

(ANAB)

AnaptysBio Inc. (ANAB)
NASDAQ

$22.52
1.14 (5.33%)

Market Cap: $602.70M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, ... read more

founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio’s proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$547,000
CEO Compensation (Total)
$5.12M
URL
Address
10421 Pacific Center Ct Ste 200, California, San Diego, 92121-4339.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Hamza Suria
CEO Compensation (Base)
$547,000
CEO Compensation (Total)
$5.12M
Address
10421 Pacific Center Ct Ste 200, California, San Diego, 92121-4339.
PRICE CHART FOR ANAPTYSBIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$21.36
Previous Close
$21.38
Days Range
$21.03 - $21.83
52 week range
$13.36 - $27.50
Volume
470,804
Avg. Volume (30 days)
383,963
Market Cap
$602.70M
Dividend Yield
-
P/E
(3.68)
Shares Outstanding
26,763,081
Open
$21.36
Previous Close
$21.38
Days Range
$21.03 - $21.83
52 week range
$13.36 - $27.50
Volume
470,804
Avg. Volume (30 days)
383,963
Market Cap
$602.70M
Dividend Yield
-
P/E
(3.68)
Shares Outstanding
26,763,081
FINANCIAL STATEMENTS FOR ANAPTYSBIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ANAPTYSBIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Faga DanielCEOMar 26, 2024 Option Exercise$21.60347,4417,504,726401,646Mar 26, 2024, 08:10 PM
Faga DanielCEOMar 25, 2024 Sale$21.423,00064,268749,087Mar 26, 2024, 08:10 PM
Faga DanielCEOMar 22, 2024 Sale$22.78145,9403,325,184752,087Mar 26, 2024, 08:10 PM
LOUMEAU ERIC JCHIEF LEGAL OFFICERFeb 16, 2024 Option Exercise$14.025,00070,1008,240Feb 21, 2024, 05:38 PM
LOUMEAU ERIC JCHIEF LEGAL OFFICERFeb 16, 2024 Sale$25.005,000125,0003,240Feb 21, 2024, 05:38 PM
MULROY DENNISCHIEF FINANCIAL OFFICERJan 30, 2024 Sale$23.633,06572,425964Feb 01, 2024, 05:27 PM
Lizzul Paul F.Chief Medical OfficerJan 08, 2024 Sale$21.812,55455,70310,118Jan 09, 2024, 07:08 PM
LOUMEAU ERIC JChief Legal OfficerJan 08, 2024 Sale$21.812,30550,2723,240Jan 09, 2024, 07:07 PM
MULROY DENNISChief Financial OfficerJan 08, 2024 Sale$21.812,18047,5464,029Jan 09, 2024, 07:06 PM
Faga DanielCEOJan 08, 2024 Sale$21.816,866149,747898,027Jan 09, 2024, 07:05 PM
LOUMEAU ERIC JChief Legal OfficerNov 22, 2023 Sale$14.1988212,5160Nov 27, 2023, 04:03 PM
Lizzul Paul F.Chief Medical OfficerSep 14, 2023 Sale$19.482,10541,0056,527Sep 18, 2023, 06:14 PM
LOUMEAU ERIC JChief Legal OfficerSep 18, 2023 Sale$19.323,89575,232882Sep 18, 2023, 06:13 PM
LOUMEAU ERIC JChief Legal OfficerSep 14, 2023 Sale$19.482,10541,0054,777Sep 18, 2023, 06:13 PM
MULROY DENNISChief Financial OfficerSep 18, 2023 Sale$19.323,89575,237964Sep 18, 2023, 06:12 PM
MULROY DENNISChief Financial OfficerSep 14, 2023 Sale$19.482,10541,0054,859Sep 18, 2023, 06:12 PM
LOUMEAU ERIC JCOO, General CounselAug 08, 2022 Sale$25.0052313,0750Aug 09, 2022, 06:03 PM
LOUMEAU ERIC JCOO, General CounselJun 08, 2022 Option Exercise$14.022,50035,0503,023Jun 10, 2022, 05:22 PM
LOUMEAU ERIC JCOO, General CounselJun 08, 2022 Sale$24.002,50060,000523Jun 10, 2022, 05:22 PM
LOUMEAU ERIC JCOO, General CounselMay 18, 2022 Sale$20.501,14623,493523May 20, 2022, 04:42 PM
EcoR1 Capital, LLC10% OwnerMay 05, 2022 Buy$21.63668,23714,453,9667,521,024May 09, 2022, 06:04 AM
EcoR1 Capital, LLC10% OwnerMay 05, 2022 Sale$21.63668,23714,453,9667,521,024May 09, 2022, 06:04 AM
Suria HamzaPresident, CEODec 20, 2021 Option Exercise$1.1236,64541,042105,245Dec 22, 2021, 06:42 PM
Suria HamzaPresident, CEODec 20, 2021 Sale$35.5736,6451,303,55993,330Dec 22, 2021, 06:42 PM
Lizzul Paul F.Chief Medical OfficerNov 15, 2021 Option Exercise$22.0396421,237964Nov 17, 2021, 05:22 PM
Suria HamzaPresident, CEONov 15, 2021 Option Exercise$22.0396421,23768,600Nov 17, 2021, 05:20 PM
LOUMEAU ERIC JCOO, General CounselNov 15, 2021 Option Exercise$22.0352311,522523Nov 17, 2021, 05:18 PM
MULROY DENNISChief Financial OfficerNov 15, 2021 Option Exercise$22.0396421,237964Nov 17, 2021, 05:16 PM
Suria HamzaPresident, CEONov 04, 2021 Option Exercise$1.126,0596,78673,695Nov 05, 2021, 06:24 PM
Suria HamzaPresident, CEONov 05, 2021 Option Exercise$1.1214,30216,01881,938Nov 05, 2021, 06:24 PM
Suria HamzaPresident, CEONov 05, 2021 Sale$35.0014,302500,57067,636Nov 05, 2021, 06:24 PM
Suria HamzaPresident, CEONov 04, 2021 Sale$35.006,059212,06567,636Nov 05, 2021, 06:24 PM
LOUMEAU ERIC JCOO, General CounselNov 04, 2021 Option Exercise$17.095,00085,4505,000Nov 05, 2021, 06:23 PM
LOUMEAU ERIC JCOO, General CounselNov 04, 2021 Sale$35.005,000175,0000Nov 05, 2021, 06:23 PM
Suria HamzaPresident, CEONov 01, 2021 Option Exercise$1.1236,64641,044104,282Nov 02, 2021, 05:53 PM
Suria HamzaPresident, CEONov 01, 2021 Sale$32.3136,6461,184,10670,195Nov 02, 2021, 05:53 PM
Suria HamzaPresident, CEOOct 26, 2021 Option Exercise$1.1215,99317,91283,629Oct 28, 2021, 07:54 PM
Suria HamzaPresident, CEOOct 26, 2021 Sale$30.0015,993479,79067,636Oct 28, 2021, 07:54 PM
Suria HamzaPresident, CEOSep 17, 2021 Option Exercise$1.1210,00011,20067,636Sep 21, 2021, 05:38 PM
Suria HamzaPresident, CEOMay 12, 2021 Option Exercise$1.1210,00011,20057,636May 13, 2021, 04:50 PM
EcoR1 Capital, LLCDirectorApr 27, 2021 Buy$23.8233,800805,0897,298,924Apr 27, 2021, 06:23 PM
EcoR1 Capital, LLCDirectorApr 26, 2021 Buy$23.8013,900330,8597,265,124Apr 27, 2021, 06:23 PM
EcoR1 Capital, LLCDirectorApr 23, 2021 Buy$23.5499,6002,344,2857,251,224Apr 27, 2021, 06:23 PM
EcoR1 Capital, LLC10% OwnerMar 08, 2021 Buy$18.972,777,80052,694,3136,620,624Mar 10, 2021, 05:53 PM
EcoR1 Capital, LLC10% OwnerMar 09, 2021 Buy$18.70531,0009,928,4257,151,624Mar 10, 2021, 05:53 PM
EcoR1 Capital, LLC10% OwnerFeb 23, 2021 Buy$25.4829,500751,6573,842,824Feb 25, 2021, 05:58 PM
LOUMEAU ERIC JCOO, General CounselFeb 12, 2021 Option Exercise$14.0210,000140,20010,000Feb 12, 2021, 09:28 PM
LOUMEAU ERIC JCOO, General CounselFeb 12, 2021 Sale$35.0010,000350,0000Feb 12, 2021, 09:28 PM
Suria HamzaPresident, CEOMar 10, 2020 Option Exercise$1.1210,00011,20047,636Mar 10, 2020, 05:02 PM
Ware J. AnthonyDirectorDec 10, 2019 Buy$14.053,60050,5803,600Feb 06, 2020, 05:48 PM
Suria HamzaPresident, CEOFeb 05, 2020 Option Exercise$1.1210,00011,20037,636Feb 06, 2020, 05:46 PM
Londei MarcoChief Medical OfficerNov 27, 2019 Option Exercise$6.9346,202320,18068,579Dec 02, 2019, 04:29 PM
Suria HamzaPresident, CEONov 22, 2019 Option Exercise$1.1210,00011,20027,636Nov 25, 2019, 04:49 PM
Suria HamzaPresident, CEOJun 10, 2019 Sale$73.7622,4281,654,35031,524Jun 12, 2019, 05:00 PM
Londei MarcoChief Medical OfficerJun 04, 2019 Option Exercise$0.7010,0607,04232,437Jun 05, 2019, 05:54 PM
Londei MarcoChief Medical OfficerJun 04, 2019 Sale$73.0610,060734,96226,428Jun 05, 2019, 05:54 PM
Suria HamzaPresident, CEOApr 17, 2019 Option Exercise$1.1210,00011,20040,064Apr 18, 2019, 06:34 PM
Suria HamzaPresident, CEOJan 14, 2019 Option Exercise$1.1240,00044,80070,064Jan 16, 2019, 07:11 PM
Suria HamzaPresident, CEOJan 14, 2019 Sale$70.7940,0002,831,53242,304Jan 16, 2019, 07:11 PM
Londei MarcoChief Medical OfficerJan 15, 2019 Option Exercise$6.9319,075132,19041,452Jan 16, 2019, 07:09 PM
Londei MarcoChief Medical OfficerJan 15, 2019 Sale$69.8819,0751,332,88237,271Jan 16, 2019, 07:09 PM
Londei MarcoChief Medical OfficerDec 17, 2018 Option Exercise$5.2630,048158,094174,925Dec 18, 2018, 09:48 PM
Londei MarcoChief Medical OfficerDec 17, 2018 Sale$66.7630,0482,005,856162,805Dec 18, 2018, 09:48 PM
Suria HamzaPresident, CEODec 14, 2018 Option Exercise$1.1241,72846,73571,792Dec 18, 2018, 09:46 PM
Suria HamzaPresident, CEODec 14, 2018 Sale$69.3641,7282,894,37546,948Dec 18, 2018, 09:46 PM
Suria HamzaPresident, CEODec 10, 2018 Option Exercise$1.1230,58734,25765,649Dec 12, 2018, 08:06 PM
Suria HamzaPresident, CEODec 12, 2018 Option Exercise$1.1230,00033,60060,064Dec 12, 2018, 08:06 PM
Suria HamzaPresident, CEODec 12, 2018 Sale$71.8630,0002,155,81748,061Dec 12, 2018, 08:06 PM
Suria HamzaPresident, CEODec 11, 2018 Sale$70.834,998354,00830,064Dec 12, 2018, 08:06 PM
Suria HamzaPresident, CEODec 10, 2018 Sale$71.1930,5872,177,58850,373Dec 12, 2018, 08:06 PM
Piscitelli DominicChief Financial OfficerDec 03, 2018 Option Exercise$11.3437,000419,58037,000Dec 04, 2018, 09:33 PM
Piscitelli DominicChief Financial OfficerDec 03, 2018 Sale$72.1437,0002,669,15833,446Dec 04, 2018, 09:33 PM
Londei MarcoChief Medical OfficerSep 07, 2018 Option Exercise$0.70142,857100,000144,877Sep 10, 2018, 07:06 PM
Suria HamzaPresident, CEOJul 09, 2018 Option Exercise$1.737,63613,19435,062Jul 11, 2018, 05:09 PM
Suria HamzaPresident, CEOJun 08, 2018 Option Exercise$2.5922,42858,08927,426Jun 11, 2018, 04:38 PM
Lydon NicholasDirectorApr 16, 2018 Sale$86.8833,0002,866,913301,506Apr 18, 2018, 04:46 PM
Lydon NicholasDirectorFeb 15, 2018 Option Exercise$4.5516,48374,998304,106Feb 20, 2018, 04:08 PM
Novo Holdings A/S10% OwnerAug 21, 2017 Sale$21.10356,3007,518,2511,936,604Aug 21, 2017, 05:11 PM
Novo Holdings A/S10% OwnerAug 15, 2017 Sale$21.00143,4283,011,9882,292,904Aug 16, 2017, 04:56 PM
Novo Holdings A/S10% OwnerAug 14, 2017 Sale$21.7935,172766,4932,436,332Aug 16, 2017, 04:56 PM
Novo Holdings A/S10% OwnerAug 07, 2017 Sale$21.10481,02310,151,4432,472,527Aug 08, 2017, 06:08 PM
Novo Holdings A/S10% OwnerAug 04, 2017 Sale$22.0010,271225,9632,952,527Aug 08, 2017, 06:08 PM
Novo Holdings A/S10% OwnerAug 03, 2017 Sale$22.0121,451472,1922,962,798Aug 03, 2017, 05:21 PM
Novo Holdings A/S10% OwnerAug 02, 2017 Sale$23.8725,700613,4852,984,249Aug 03, 2017, 05:21 PM
Novo Holdings A/S10% OwnerAug 01, 2017 Sale$23.8723,555562,2703,009,949Aug 03, 2017, 05:21 PM
Avalon Ventures VII L P10% OwnerJul 26, 2017 Sale$24.3537,040901,9240Jul 28, 2017, 03:52 PM
Frazier Healthcare VII, L.P.10% OwnerFeb 02, 2017 Option Exercise$4.55117,235533,4192,345,612Feb 06, 2017, 05:14 PM
Frazier Healthcare V, LP10% OwnerFeb 02, 2017 Option Exercise$4.55117,235533,4192,345,612Feb 06, 2017, 05:14 PM
Novo A/S10% OwnerJan 31, 2017 Buy$15.0050,000750,0003,033,504Feb 01, 2017, 04:22 PM
Topper James NDirectorJan 31, 2017 Buy$15.00400,0006,000,0001,045,031Jan 31, 2017, 04:51 PM
Lydon NicholasDirectorJan 31, 2017 Buy$15.0016,666249,990287,623Jan 31, 2017, 04:49 PM
Frazier Healthcare VII, L.P.10% OwnerJan 31, 2017 Buy$15.0088,7091,330,63588,709Jan 31, 2017, 04:20 PM
Frazier Healthcare VII, L.P.10% OwnerJan 31, 2017 Buy$15.00311,2914,669,365311,291Jan 31, 2017, 04:20 PM
Frazier Healthcare V, LP10% OwnerJan 31, 2017 Buy$15.00400,0006,000,000311,291Jan 31, 2017, 04:16 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Faga DanielCEO03/26/20247,504,726
Faga DanielCEO03/25/202464,268
Faga DanielCEO03/22/20243,325,184
LOUMEAU ERIC JCHIEF LEGAL OFFICER02/16/202470,100
LOUMEAU ERIC JCHIEF LEGAL OFFICER02/16/2024125,000
MULROY DENNISCHIEF FINANCIAL OFFICER01/30/202472,425
Lizzul Paul F.Chief Medical Officer01/08/202455,703
LOUMEAU ERIC JChief Legal Officer01/08/202450,272
MULROY DENNISChief Financial Officer01/08/202447,546
Faga DanielCEO01/08/2024149,747
LOUMEAU ERIC JChief Legal Officer11/22/202312,516
Lizzul Paul F.Chief Medical Officer09/14/202341,005
LOUMEAU ERIC JChief Legal Officer09/18/202375,232
LOUMEAU ERIC JChief Legal Officer09/14/202341,005
MULROY DENNISChief Financial Officer09/18/202375,237
MULROY DENNISChief Financial Officer09/14/202341,005
LOUMEAU ERIC JCOO, General Counsel08/08/202213,075
LOUMEAU ERIC JCOO, General Counsel06/08/202235,050
LOUMEAU ERIC JCOO, General Counsel06/08/202260,000
LOUMEAU ERIC JCOO, General Counsel05/18/202223,493
EcoR1 Capital, LLC10% Owner05/05/202214,453,966
EcoR1 Capital, LLC10% Owner05/05/202214,453,966
Suria HamzaPresident, CEO12/20/202141,042
Suria HamzaPresident, CEO12/20/20211,303,559
Lizzul Paul F.Chief Medical Officer11/15/202121,237
Suria HamzaPresident, CEO11/15/202121,237
LOUMEAU ERIC JCOO, General Counsel11/15/202111,522
MULROY DENNISChief Financial Officer11/15/202121,237
Suria HamzaPresident, CEO11/04/20216,786
Suria HamzaPresident, CEO11/05/202116,018
Suria HamzaPresident, CEO11/05/2021500,570
Suria HamzaPresident, CEO11/04/2021212,065
LOUMEAU ERIC JCOO, General Counsel11/04/202185,450
LOUMEAU ERIC JCOO, General Counsel11/04/2021175,000
Suria HamzaPresident, CEO11/01/202141,044
Suria HamzaPresident, CEO11/01/20211,184,106
Suria HamzaPresident, CEO10/26/202117,912
Suria HamzaPresident, CEO10/26/2021479,790
Suria HamzaPresident, CEO09/17/202111,200
Suria HamzaPresident, CEO05/12/202111,200
EcoR1 Capital, LLCDirector04/27/2021805,089
EcoR1 Capital, LLCDirector04/26/2021330,859
EcoR1 Capital, LLCDirector04/23/20212,344,285
EcoR1 Capital, LLC10% Owner03/08/202152,694,313
EcoR1 Capital, LLC10% Owner03/09/20219,928,425
EcoR1 Capital, LLC10% Owner02/23/2021751,657
LOUMEAU ERIC JCOO, General Counsel02/12/2021140,200
LOUMEAU ERIC JCOO, General Counsel02/12/2021350,000
Suria HamzaPresident, CEO03/10/202011,200
Ware J. AnthonyDirector12/10/201950,580
Suria HamzaPresident, CEO02/05/202011,200
Londei MarcoChief Medical Officer11/27/2019320,180
Suria HamzaPresident, CEO11/22/201911,200
Suria HamzaPresident, CEO06/10/20191,654,350
Londei MarcoChief Medical Officer06/04/20197,042
Londei MarcoChief Medical Officer06/04/2019734,962
Suria HamzaPresident, CEO04/17/201911,200
Suria HamzaPresident, CEO01/14/201944,800
Suria HamzaPresident, CEO01/14/20192,831,532
Londei MarcoChief Medical Officer01/15/2019132,190
Londei MarcoChief Medical Officer01/15/20191,332,882
Londei MarcoChief Medical Officer12/17/2018158,094
Londei MarcoChief Medical Officer12/17/20182,005,856
Suria HamzaPresident, CEO12/14/201846,735
Suria HamzaPresident, CEO12/14/20182,894,375
Suria HamzaPresident, CEO12/10/201834,257
Suria HamzaPresident, CEO12/12/201833,600
Suria HamzaPresident, CEO12/12/20182,155,817
Suria HamzaPresident, CEO12/11/2018354,008
Suria HamzaPresident, CEO12/10/20182,177,588
Piscitelli DominicChief Financial Officer12/03/2018419,580
Piscitelli DominicChief Financial Officer12/03/20182,669,158
Londei MarcoChief Medical Officer09/07/2018100,000
Suria HamzaPresident, CEO07/09/201813,194
Suria HamzaPresident, CEO06/08/201858,089
Lydon NicholasDirector04/16/20182,866,913
Lydon NicholasDirector02/15/201874,998
Novo Holdings A/S10% Owner08/21/20177,518,251
Novo Holdings A/S10% Owner08/15/20173,011,988
Novo Holdings A/S10% Owner08/14/2017766,493
Novo Holdings A/S10% Owner08/07/201710,151,443
Novo Holdings A/S10% Owner08/04/2017225,963
Novo Holdings A/S10% Owner08/03/2017472,192
Novo Holdings A/S10% Owner08/02/2017613,485
Novo Holdings A/S10% Owner08/01/2017562,270
Avalon Ventures VII L P10% Owner07/26/2017901,924
Frazier Healthcare VII, L.P.10% Owner02/02/2017533,419
Frazier Healthcare V, LP10% Owner02/02/2017533,419
Novo A/S10% Owner01/31/2017750,000
Topper James NDirector01/31/20176,000,000
Lydon NicholasDirector01/31/2017249,990
Frazier Healthcare VII, L.P.10% Owner01/31/20171,330,635
Frazier Healthcare VII, L.P.10% Owner01/31/20174,669,365
Frazier Healthcare V, LP10% Owner01/31/20176,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ANAPTYSBIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.1,799,8230.00098%-1.32%Other
PALO ALTO INVESTORS LP686,8821.33%59.29%Other
SUVRETTA CAPITAL MANAGEMENT, LLC354,8720.34%-25.98%Growth At A Reasonable Price
GEODE CAPITAL MANAGEMENT, LLC420,1050.00094%5.13%Other
BLACKSTONE INC.328,7200.03%No changeOther
D. E. SHAW & CO., INC.160,3260.003%9.89%Other
UBS OCONNOR LLC87,1240.13%-30%Value
BAKER BROS. ADVISORS LP106,1970.01%ExitedOther
RENAISSANCE TECHNOLOGIES LLC95,6000.00317%3.13%Other
FISHER ASSET MANAGEMENT, LLC71,1540.00081%0.71%Other
ALPS ADVISORS INC18,0680.00304%-7.69%Other
BALYASNY ASSET MANAGEMENT L.P.18,9480.00076%NewEvent Driven
AQR CAPITAL MANAGEMENT LLC16,6820.00067%NewOther
TUDOR INVESTMENT CORP ET AL9,9390.00171%NewEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR ANAPTYSBIO INC
STOCK BUYBACKS FOR ANAPTYSBIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.14%
1Q
12/31/2023
06/30/2023
-0.18%
2Q
12/31/2023
03/31/2023
-4.90%
3Q
12/31/2023
12/31/2022
-6.56%
4Q
12/31/2023
09/30/2022
-6.03%
5Q
12/31/2023
06/30/2022
-5.75%
6Q
12/31/2023
03/31/2022
-4.08%
7Q
12/31/2023
12/31/2021
-3.45%
8Q
12/31/2023
09/30/2021
-3.11%
9Q
12/31/2023
06/30/2021
-2.95%
10Q
12/31/2023
03/31/2021
-2.85%
11Q
12/31/2023
12/31/2020
-2.81%
12Q
12/31/2023
09/30/2020
-2.69%
13Q
12/31/2023
06/30/2020
-2.56%
14Q
12/31/2023
03/31/2020
-2.50%
15Q
12/31/2023
12/31/2019
-2.16%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.14%
1Q
06/30/2023
-0.18%
2Q
03/31/2023
-4.90%
3Q
12/31/2022
-6.56%
4Q
09/30/2022
-6.03%
5Q
06/30/2022
-5.75%
6Q
03/31/2022
-4.08%
7Q
12/31/2021
-3.45%
8Q
09/30/2021
-3.11%
9Q
06/30/2021
-2.95%
10Q
03/31/2021
-2.85%
11Q
12/31/2020
-2.81%
12Q
09/30/2020
-2.69%
13Q
06/30/2020
-2.56%
14Q
03/31/2020
-2.50%
15Q
12/31/2019
-2.16%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ANAPTYSBIO INC
LOADING...